Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 122

1.

Olecranon bursitis secondary to Mycobacterium europaeum infection in a patient receiving immunosuppressive drugs for rheumatoid arthritis.

Dutertre M, Delobel P, Marchou B, Boyer JF, Mougari F, Martin-Blondel G.

Med Mal Infect. 2019 May 14. pii: S0399-077X(17)30890-9. doi: 10.1016/j.medmal.2019.03.002. [Epub ahead of print] No abstract available.

PMID:
31097371
2.

Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection.

Gantner P, Cotte L, Allavena C, Bani-Sadr F, Huleux T, Duvivier C, Valantin MA, Jacomet C, Joly V, Chéret A, Pugliese P, Delobel P, Cabié A, Rey D; Dat’AIDS Study Group.

PLoS One. 2019 Apr 18;14(4):e0215464. doi: 10.1371/journal.pone.0215464. eCollection 2019.

3.

Treatment of Progressive Multifocal Leukoencephalopathy with Nivolumab.

Walter O, Treiner E, Bonneville F, Mengelle C, Vergez F, Lerebours F, Delobel P, Liblau R, Martin-Blondel G; Immune Checkpoint Inhibitors in PML Study Group.

N Engl J Med. 2019 Apr 25;380(17):1674-1676. doi: 10.1056/NEJMc1816198. Epub 2019 Apr 10. No abstract available.

PMID:
30969500
4.

Increase of CXCR3+ T cells impairs Th17 cells recruitment in the small intestine mucosa through IFN-γ and IL-18 during treated HIV-1 infection.

Loiseau C, Requena M, Nayrac M, Mavigner M, Cazabat M, Iscache AL, Carrere N, Suc B, Alric L, Izopet J, Delobel P.

J Infect Dis. 2019 Mar 18. pii: jiz123. doi: 10.1093/infdis/jiz123. [Epub ahead of print]

PMID:
30880342
5.

Efficacy of teicoplanin monotherapy following initial standard therapy in Enterococcus faecalis infective endocarditis: a retrospective cohort study.

De Nadaï T, François M, Sommet A, Dubois D, Metsu D, Grare M, Marchou B, Delobel P, Martin-Blondel G.

Infection. 2019 Jun;47(3):463-469. doi: 10.1007/s15010-019-01290-w. Epub 2019 Feb 27.

PMID:
30809761
6.

Added value of [18F]fluorodeoxyglucose positron emission tomography/computed tomography for the diagnosis of post-operative instrumented spine infection.

Follenfant E, Balamoutoff N, Lawson-Ayayi S, Dutronc H, Dupon M, Vital JM, Delobel P, Durox H, de Clermont-Gallerande H, Fernandez P, Dauchy FA.

Joint Bone Spine. 2019 Jul;86(4):503-508. doi: 10.1016/j.jbspin.2019.01.009. Epub 2019 Jan 31.

PMID:
30711697
7.

HIV-1 escape in the central nervous system on elvitegravir-based antiretroviral therapy.

Guerveno C, Raymond S, Metsu D, Gandia P, Izopet J, Martin-Blondel G, Delobel P.

AIDS. 2019 Mar 1;33(3):593-594. doi: 10.1097/QAD.0000000000002089. No abstract available.

PMID:
30702524
8.

[Refractory cutaneous leishmaniasis: Benefit of miltefosine].

Guerveno C, Delavigne K, Berry A, Martin-Blondel G, Delobel P.

Med Mal Infect. 2019 Jun;49(4):281-283. doi: 10.1016/j.medmal.2018.11.009. Epub 2018 Dec 13. French. No abstract available.

PMID:
30554949
9.

CCR5 structural plasticity shapes HIV-1 phenotypic properties.

Colin P, Zhou Z, Staropoli I, Garcia-Perez J, Gasser R, Armani-Tourret M, Benureau Y, Gonzalez N, Jin J, Connell BJ, Raymond S, Delobel P, Izopet J, Lortat-Jacob H, Alcami J, Arenzana-Seisdedos F, Brelot A, Lagane B.

PLoS Pathog. 2018 Dec 6;14(12):e1007432. doi: 10.1371/journal.ppat.1007432. eCollection 2018 Dec.

10.

Once-daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS-165 DARULIGHT study.

Lê MP, Chaix ML, Raffi F, Chevret S, Gallien S, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G; ANRS-165 DARULIGHT study group.

Br J Clin Pharmacol. 2019 Jan;85(1):277-280. doi: 10.1111/bcp.13796. Epub 2018 Nov 12. No abstract available.

PMID:
30421447
11.

Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial.

Palich R, Ghosn J, Chaillon A, Boilet V, Nere ML, Chaix ML, Delobel P, Molina JM, Lucht F, Bouchaud O, Rieux V, Thiebaut R, Levy Y, Delaugerre C, Lelievre JD; VRI02/ANRS149 LIGHT Vaccine Trial Group.

AIDS. 2019 Feb 1;33(2):279-284. doi: 10.1097/QAD.0000000000002058.

PMID:
30325777
12.

Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients.

Allavena C, Hanf M, Rey D, Duvivier C, BaniSadr F, Poizot-Martin I, Jacomet C, Pugliese P, Delobel P, Katlama C, Joly V, Chidiac C, Dournon N, Merrien D, May T, Reynes J, Gagneux-Brunon A, Chirouze C, Huleux T, Cabié A, Raffi F; Dat’AIDS study group.

PLoS One. 2018 Sep 21;13(9):e0203895. doi: 10.1371/journal.pone.0203895. eCollection 2018.

13.

Zoster after Cyclophosphamide for Systemic Lupus Erythematosus or Vasculitis: Incidence, Risk Factors, and Effect of Antiviral Prophylaxis.

Garnier C, Ribes D, Chauveau D, Huart A, Pugnet G, Adoue D, Prevot G, Alric L, Delobel P, Derumeaux H, Mengelle C, Sailler L, Moulis G.

J Rheumatol. 2018 Nov;45(11):1541-1548. doi: 10.3899/jrheum.180310. Epub 2018 Jul 15.

PMID:
30008461
14.

Hepatitis C virus incidence in HIV-infected and in preexposure prophylaxis (PrEP)-using men having sex with men.

Cotte L, Cua E, Reynes J, Raffi F, Rey D, Delobel P, Gagneux-Brunon A, Jacomet C, Palich R, Laroche H, Cabie A, Hoen B, Chidiac C, Pradat P; Dat'AIDS study Group.

Liver Int. 2018 Jun 30. doi: 10.1111/liv.13922. [Epub ahead of print]

PMID:
29959866
15.

Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.

Lê MP, Chaix ML, Chevret S, Bertrand J, Raffi F, Gallien S, El Abbassi EMB, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G; ANRS 165 DARULIGHT Study Group .

J Antimicrob Chemother. 2018 Aug 1;73(8):2120-2128. doi: 10.1093/jac/dky193.

PMID:
29905808
16.

Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight).

Molina JM, Gallien S, Chaix ML, El Abbassi EM, Madelaine I, Katlama C, Valin N, Delobel P, Desseaux K, Peytavin G, Saillard J, Raffi F, Chevret S; ANRS 165 Darulight Study Group .

J Antimicrob Chemother. 2018 Aug 1;73(8):2129-2136. doi: 10.1093/jac/dky181.

PMID:
29860402
17.

Performance comparison of deep sequencing platforms for detecting HIV-1 variants in the pol gene.

Nicot F, Jeanne N, Raymond S, Delfour O, Carcenac R, Lefebvre C, Sauné K, Delobel P, Izopet J.

J Med Virol. 2018 Sep;90(9):1486-1492. doi: 10.1002/jmv.25224. Epub 2018 May 25.

PMID:
29750364
19.

HIV-1 genotypic resistance testing using the Vela automated next-generation sequencing platform.

Raymond S, Nicot F, Carcenac R, Lefebvre C, Jeanne N, Saune K, Delobel P, Izopet J.

J Antimicrob Chemother. 2018 May 1;73(5):1152-1157. doi: 10.1093/jac/dky003.

PMID:
29444253
20.

Incidence of new hepatitis C virus infection is still increasing in French MSM living with HIV.

Pradat P, Huleux T, Raffi F, Delobel P, Valantin MA, Poizot-Martin I, Pugliese P, Reynes J, Rey D, Hoen B, Cabie A, Bani-Sadr F, Cheret A, Duvivier C, Jacomet C, Fresard A, Hustache-Mathieu L, Cotte L; Dat’AIDS study Group.

AIDS. 2018 May 15;32(8):1077-1082. doi: 10.1097/QAD.0000000000001789.

PMID:
29438195
21.

Determination of dolutegravir's unbound fraction in human plasma using validated equilibrium dialysis and LC-MS/MS methods.

Metsu D, Lanot T, Fraissinet F, Picot M, Concordet D, Cabrol M, Dubois-Galopin F, Chatelut E, Delobel P, Gandia P.

Clin Chim Acta. 2018 Apr;479:56-65. doi: 10.1016/j.cca.2017.12.034. Epub 2017 Dec 22.

PMID:
29277535
22.

Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen.

Raffi F, Hanf M, Ferry T, Khatchatourian L, Joly V, Pugliese P, Katlama C, Robineau O, Chirouze C, Jacomet C, Delobel P, Poizot-Martin I, Ravaux I, Duvivier C, Gagneux-Brunon A, Rey D, Reynes J, May T, Bani-Sadr F, Hoen B, Morrier M, Cabie A, Allavena C; Dat’AIDS Study Group.

J Antimicrob Chemother. 2017 Dec 1;72(12):3502. doi: 10.1093/jac/dkx383. No abstract available.

PMID:
29121210
23.

Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen.

Raffi F, Hanf M, Ferry T, Khatchatourian L, Joly V, Pugliese P, Katlama C, Robineau O, Chirouze C, Jacomet C, Delobel P, Poizot-Martin I, Ravaux I, Duvivier C, Gagneux-Brunon A, Rey D, Reynes J, May T, Bani-Sadr F, Hoen B, Morrier M, Cabie A, Allavena C; Dat’AIDS Study Group.

J Antimicrob Chemother. 2017 Dec 1;72(12):3425-3434. doi: 10.1093/jac/dkx300. Erratum in: J Antimicrob Chemother. 2017 Dec 1;72(12):3502.

PMID:
28961719
24.

Outcomes for HIV-associated diffuse large B-cell lymphoma in the modern combined antiretroviral therapy era.

Besson C, Lancar R, Prevot S, Algarte-Genin M, Delobel P, Bonnet F, Meyohas MC, Partisani M, Oberic L, Gabarre J, Goujard C, Boue F, Coppo P, Costello R, Hendel-Chavez H, Mekerri N, Dos Santos G, Recher C, Delarue R, Casasnovas RO, Taoufik Y, Mounier N, Costagliola D; ANRS-CO16 LYMPHOVIR Cohort.

AIDS. 2017 Nov 28;31(18):2493-2501. doi: 10.1097/QAD.0000000000001652.

PMID:
28926410
25.

Experiences of HIV postexposure prophylaxis (PEP) among highly exposed men who have sex with men (MSM).

Palich R, Martin-Blondel G, Cuzin L, Le Talec JY, Boyer P, Massip P, Delobel P.

Sex Transm Infect. 2017 Nov;93(7):493-498. doi: 10.1136/sextrans-2016-052901. Epub 2017 Jul 24.

PMID:
28739808
26.

Antiretroviral unbound concentration during pregnancy: piece of interest in the puzzle?

Metsu D, Toutain PL, Chatelut E, Delobel P, Gandia P.

J Antimicrob Chemother. 2017 Sep 1;72(9):2407-2409. doi: 10.1093/jac/dkx176.

PMID:
28595364
27.

Identification by highly sensitive 16S metagenomic sequencing of an unusual case of polymicrobial bacteremia.

Lelouvier B, Servant F, Delobel P, Courtney M, Elbaz M, Amar J.

J Infect. 2017 Sep;75(3):278-280. doi: 10.1016/j.jinf.2017.05.005. Epub 2017 May 20. No abstract available.

PMID:
28535999
28.

Initiation of Antiretroviral Therapy Containing Integrase Inhibitors Increases the Risk of IRIS Requiring Hospitalization.

Dutertre M, Cuzin L, Demonchy E, Puglièse P, Joly V, Valantin MA, Cotte L, Huleux T, Delobel P, Martin-Blondel G; DatʼAIDS Study Group.

J Acquir Immune Defic Syndr. 2017 Sep 1;76(1):e23-e26. doi: 10.1097/QAI.0000000000001397. No abstract available.

PMID:
28418992
29.

Zika Virus Infection and Prolonged Viremia in Whole-Blood Specimens.

Mansuy JM, Mengelle C, Pasquier C, Chapuy-Regaud S, Delobel P, Martin-Blondel G, Izopet J.

Emerg Infect Dis. 2017 May;23(5):863-865. doi: 10.3201/eid2305.161631. Epub 2017 May 15.

30.

Performance comparison of next-generation sequencing platforms for determining HIV-1 coreceptor use.

Raymond S, Nicot F, Jeanne N, Delfour O, Carcenac R, Lefebvre C, Cazabat M, Sauné K, Delobel P, Izopet J.

Sci Rep. 2017 Feb 10;7:42215. doi: 10.1038/srep42215.

31.

HEV infection in French HIV-infected patients.

Abravanel F, Lhomme S, Fougère M, Saune K, Alvarez M, Péron JM, Delobel P, Izopet J.

J Infect. 2017 Mar;74(3):310-313. doi: 10.1016/j.jinf.2016.12.004. Epub 2016 Dec 18.

PMID:
27998748
32.

Is the unbound concentration of atazanavir of interest in therapeutic drug monitoring?

Metsu D, Seraissol P, Delobel P, Cinq-Frais C, Cuzin L, Izopet J, Chatelut E, Gandia P.

Fundam Clin Pharmacol. 2017 Apr;31(2):245-253. doi: 10.1111/fcp.12245. Epub 2016 Oct 25.

PMID:
27664801
33.

Zika virus in semen and spermatozoa.

Mansuy JM, Suberbielle E, Chapuy-Regaud S, Mengelle C, Bujan L, Marchou B, Delobel P, Gonzalez-Dunia D, Malnou CE, Izopet J, Martin-Blondel G.

Lancet Infect Dis. 2016 Oct;16(10):1106-1107. doi: 10.1016/S1473-3099(16)30336-X. Epub 2016 Sep 19. No abstract available.

PMID:
27676340
34.

Long-term efficacy and toxicity of abacavir/lamivudine/nevirapine compared to the most prescribed ARV regimens before 2013 in a French Nationwide Cohort Study.

de Boissieu P, Dramé M, Raffi F, Cabie A, Poizot-Martin I, Cotte L, Garraffo R, Delobel P, Huleux T, Rey D, Bani-Sadr F; Dat’AIDS Study Group.

Medicine (Baltimore). 2016 Sep;95(37):e4890. doi: 10.1097/MD.0000000000004890.

35.

A case report of isolated lymphadenopathy revealing localized leishmanial lymphadenopathy in an asthenic 25-year-old man.

Hurlot Q, Fillaux J, Laurent C, Berry A, Hofman P, Marchou B, Delobel P, Brousset P, Martin-Blondel G.

Medicine (Baltimore). 2016 Jul;95(29):e3932. doi: 10.1097/MD.0000000000003932.

36.

Viral load kinetics of Zika virus in plasma, urine and saliva in a couple returning from Martinique, French West Indies.

Fourcade C, Mansuy JM, Dutertre M, Delpech M, Marchou B, Delobel P, Izopet J, Martin-Blondel G.

J Clin Virol. 2016 Sep;82:1-4. doi: 10.1016/j.jcv.2016.06.011. Epub 2016 Jun 22.

PMID:
27389909
37.

Use of rifampin for treatment of disseminated tuberculosis in a patient with primary myelofibrosis on ruxolitinib.

Branco B, Metsu D, Dutertre M, Marchou B, Delobel P, Recher C, Martin-Blondel G.

Ann Hematol. 2016 Jun;95(7):1207-9. doi: 10.1007/s00277-016-2684-0. Epub 2016 Apr 26. No abstract available.

PMID:
27113251
38.

Brief Report: HIV-1 Tropism During Primary Infections in France: 1996-2014.

Raymond S, Nicot F, Sauné K, Cazabat M, Pasquier C, Massip P, Marchou B, Delobel P, Izopet J.

J Acquir Immune Defic Syndr. 2016 Aug 1;72(4):376-9. doi: 10.1097/QAI.0000000000000984.

PMID:
26959188
39.

Zika virus: high infectious viral load in semen, a new sexually transmitted pathogen?

Mansuy JM, Dutertre M, Mengelle C, Fourcade C, Marchou B, Delobel P, Izopet J, Martin-Blondel G.

Lancet Infect Dis. 2016 Apr;16(4):405. doi: 10.1016/S1473-3099(16)00138-9. Epub 2016 Mar 4. No abstract available.

PMID:
26949027
40.

CCR6(-) regulatory T cells blunt the restoration of gut Th17 cells along the CCR6-CCL20 axis in treated HIV-1-infected individuals.

Loiseau C, Requena M, Mavigner M, Cazabat M, Carrere N, Suc B, Barange K, Alric L, Marchou B, Massip P, Izopet J, Delobel P.

Mucosal Immunol. 2016 Sep;9(5):1137-50. doi: 10.1038/mi.2016.7. Epub 2016 Feb 17.

PMID:
26883727
41.

Evidence for a permanent presence of schistosomiasis in Corsica, France, 2015.

Berry A, Fillaux J, Martin-Blondel G, Boissier J, Iriart X, Marchou B, Magnaval JF, Delobel P.

Euro Surveill. 2016;21(1). doi: 10.2807/1560-7917.ES.2016.21.1.30100.

42.

Favorable outcome of severe human herpes virus-6 encephalitis in an HIV-infected patient.

Barigou M, Garnier C, Debard A, Mengelle C, Dumas H, Porte L, Delobel P, Bonneville F, Marchou B, Martin-Blondel G.

AIDS. 2016 Jan 28;30(3):532-4. doi: 10.1097/QAD.0000000000000973. No abstract available.

PMID:
26760237
43.

Long-term efficacy and safety of etravirine-containing regimens in a real-life cohort of treatment-experienced HIV-1-infected patients.

Allavena C, Katlama C, Cotte L, Roger PM, Delobel P, Cheret A, Duvivier C, Poizot-Martin I, Hoen B, Cabie A, Cheret A, Lahoulou R, Raffi F, Pugliese P; Dat’AIDS Study group.

Infect Dis (Lond). 2016;48(5):392-8. doi: 10.3109/23744235.2015.1133927. Epub 2016 Jan 13.

PMID:
26757613
44.

No selection of CXCR4-using variants in cell reservoirs of dual-mixed HIV-infected patients on suppressive maraviroc therapy.

Raymond S, Nicot F, Carcenac R, Jeanne N, Cazabat M, Requena M, Cuzin L, Delobel P, Izopet J; ANRS 145 MARIMUNO Study Group.

AIDS. 2016 Mar 27;30(6):965-8. doi: 10.1097/QAD.0000000000001013.

PMID:
26752281
45.

Position-specific automated processing of V3 env ultra-deep pyrosequencing data for predicting HIV-1 tropism.

Jeanne N, Saliou A, Carcenac R, Lefebvre C, Dubois M, Cazabat M, Nicot F, Loiseau C, Raymond S, Izopet J, Delobel P.

Sci Rep. 2015 Nov 20;5:16944. doi: 10.1038/srep16944.

46.

Isolation on Chocolate Agar Culture of Legionella pneumophila Isolates from Subcutaneous Abscesses in an Immunocompromised Patient.

Barigou M, Cavalie L, Daviller B, Dubois D, Mantion B, Delobel P, Debard A, Prere MF, Marchou B, Martin-Blondel G.

J Clin Microbiol. 2015 Nov;53(11):3683-5. doi: 10.1128/JCM.01116-15. Epub 2015 Aug 19.

47.

HIV-1 Tat Protein Induces Production of Proinflammatory Cytokines by Human Dendritic Cells and Monocytes/Macrophages through Engagement of TLR4-MD2-CD14 Complex and Activation of NF-κB Pathway.

Ben Haij N, Planès R, Leghmari K, Serrero M, Delobel P, Izopet J, BenMohamed L, Bahraoui E.

PLoS One. 2015 Jun 19;10(6):e0129425. doi: 10.1371/journal.pone.0129425. eCollection 2015.

48.

Intra-nodal injection of gentamicin for the treatment of suppurated cat scratch disease's lymphadenitis.

Garnier C, Martin-Blondel G, Debuisson C, Dubois D, Debard A, Cuzin L, Massip P, Delobel P, Marchou B.

Infection. 2016 Feb;44(1):23-7. doi: 10.1007/s15010-015-0797-3. Epub 2015 May 23.

PMID:
26001741
49.

Minority resistant HIV-1 variants and the response to first-line NNRTI therapy.

Nicot F, Sauné K, Raymond S, Jeanne N, Carcenac R, Lefebvre C, Cuzin L, Marchou B, Delobel P, Izopet J.

J Clin Virol. 2015 Jan;62:20-4. doi: 10.1016/j.jcv.2014.10.020. Epub 2014 Nov 20.

PMID:
25542465
50.

Deciphering regulatory variation of THI genes in alcoholic fermentation indicate an impact of Thi3p on PDC1 expression.

Brion C, Ambroset C, Delobel P, Sanchez I, Blondin B.

BMC Genomics. 2014 Dec 10;15:1085. doi: 10.1186/1471-2164-15-1085.

Supplemental Content

Loading ...
Support Center